{"pageContent": "Introduction/background: Only 1 randomized controlled trial has compared focal therapy and active surveillance (AS) for the low-risk prostate cancer (PCa). We investigated whether focal HIFU (fHIFU) yields oncologic advantages over AS for low-risk PCa.", "metaData": {"source": "Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study\nhttps://pubmed.ncbi.nlm.nih.gov/25682339/"}}